PubMed COVID-19 Clinical Care

CONCLUSIONS: Overall, innovations and measures adopted during the pandemic protected cancer patients; however, some groups were particularly vulnerable, and inequalities may have widened further. Only proven effective and efficient innovations

No abstract

By the end of 2022, different variants of Omicron had rapidly spread worldwide, causing a significant impact on the Coronavirus disease 2019 (COVID-19) pandemic situation. Compared with previous variants of severe acute respiratory syndrome

CONCLUSION: UVC cabinets and carousels demonstrated Phi6 reductions that could augment routine cleaning measures for reusable respirators. In real-world scenarios, germicidal UVC devices could therefore potentially offer benefits for reducing contact

Pulmonary thromboembolism (PTE) is a common complication in coronavirus disease 2019 (COVID-19) patients. Elevated D-dimer levels are observed even in the absence of PTE, reducing its discriminative ability as a screening test. It is unknown whether

TAFRO syndrome is a systemic inflammatory disorder, which is characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly. It often presents with progressive clinical symptoms and can be fatal

No abstract

CONCLUSIONS: Our primary findings underscore the connection between psychological distress and emotion regulation, specifically between depressive symptoms, a lack of emotional clarity, and difficulty in the flexible use of emotional strategies

No abstract

Scientific evidence regularly guides policy decisions¹, with behavioural science increasingly part of this process². In April 2020, an influential paper³ proposed 19 policy recommendations ('claims') detailing how evidence from behavioural science